Emcure Pharmaceuticals Limited - Balance (Quarterly)

Emcure Pharmaceuticals Limited
IN ˙ BSE ˙ INE168P01015
1.640,15 ₹ ↑30,10 (1,87%)
2026-04-24
DEL PRIS
Balance (Quarterly)

Emcure Pharmaceuticals Limited Balance viser kontosaldi for virksomheden på tidspunkter. Balancedata inkluderer aktiver, omsætningsaktiver, anlægsaktiver, materielle anlægsaktiver (PPE), inventar, immaterielle aktiver, passiver, kortfristede forpligtelser, gæld, kapitalleasingforpligtelser, almindelige aktier, overført overskud, egne aktier og egenkapital.

Alle tal er gange 1,000,000.00 undtagen pr. andel enheder.

2022
03-31
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
Kontanter 1.628 2.423 3.443 1.690 1.871 1.555 4.896
Ændring (%) 48,81 42,07 -50,91 10,72 -16,88 214,75
Aktiver Nuværende 34.241 38.359 38.672 42.599 44.558 45.559 56.055
Ændring (%) 12,03 0,82 10,15 4,60 2,24 23,04
Aktiver 60.635 66.725 67.150 78.062 81.245 82.327 93.925
Ændring (%) 10,04 0,64 16,25 4,08 1,33 14,09
Forpligtelser 39.493 40.229 38.008 46.844 38.212 35.912 45.085
Ændring (%) 1,86 -5,52 23,25 -18,43 -6,02 25,54
Egenkapital 21.141 26.497 29.142 31.218 43.033 46.416 48.840
Ændring (%) 25,33 9,99 7,12 37,85 7,86 5,22
Passiver og Aktiekapital 60.635 66.725 67.150 78.062 81.245 82.327 93.925
Ændring (%) 10,04 0,64 16,25 4,08 1,33 14,09

Source: Capital IQ

Other Listings
IN:EMCURE 1.640,15 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista